Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Irene Ayakaka, Mari Armstrong-Hough, Alisse Hannaford, Joseph M. Ggita, Patricia Turimumahoro, Achilles Katamba, Anne Katahoire, Adithya Cattamanchi, Sheela V. Shenoi & J. L. Davis. (2022) Perceptions, preferences, and experiences of tuberculosis education and counselling among patients and providers in Kampala, Uganda: A qualitative study. Global Public Health 17:11, pages 2911-2928.
Read now
Read now
Doris Burtscher, Pia Juul Bjertrup, Debrah Vambe, Velibanti Dlamini, Nqobile Mmema, Siphiwe Ngwenya, Barbara Rusch & Bernhard Kerschberger. (2021) ‘She is like my mother’: Community-based care of drug-resistant tuberculosis in rural Eswatini. Global Public Health 16:6, pages 911-923.
Read now
Read now
Kogieleum Naidoo, Navisha Dookie, Kasavan Naidoo, Nonhlanhla Yende-Zuma, Benjamin Chimukangara, Ambika Bhushan, Dhineshree Govender, Santhanalakshmi Gengiah & Nesri Padayatchi. (2018) Recurrent tuberculosis among HIV co-infected patients: A Case Series from KwaZulu-Natal. Infection and Drug Resistance 11, pages 1413-1421.
Read now
Read now
Karen B. Jacobson, Linda Niccolai, Nonhle Mtungwa, Anthony P. Moll & Sheela V. Shenoi. (2017) “It’s about my life”: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care 29:7, pages 936-942.
Read now
Read now
Jabulani G. Kheswa. (2017) Exploring the Factors and Effects of Non-Adherence to Antiretroviral Treatment by People Living with HIV/AIDS. Indo-Pacific Journal of Phenomenology 17:1, pages 1-11.
Read now
Read now
Nesri Padayatchi, Sharana Mahomed, Marian Loveday & Kogieleum Naidoo. (2016) Antibiotic stewardship for drug resistant tuberculosis. Expert Opinion on Pharmacotherapy 17:15, pages 1981-1983.
Read now
Read now
Articles from other publishers (40)
Joan Rokani Bayowa, Joan N. Kalyango, Joseph Baruch Baluku, Richard Katuramu, Emmanuel Ssendikwanawa, Jane Frances Zalwango, Rebecca Akunzirwe, Stella Maris Nanyonga, Judith Ssemasazi Amutuhaire, Ronald Kivumbi Muganga & Adolphus Cherop. (2023) Mortality rate and associated factors among patients co-infected with drug resistant tuberculosis/HIV at Mulago National Referral Hospital, Uganda, a retrospective cohort study. PLOS Global Public Health 3:7, pages e0001020.
Crossref
Crossref
Liberate Mleoh, Shabani Ramadhani Mziray, Donatus Tsere, Inge Koppelaar, Christiaan Mulder & Dennis Lyakurwa. (2023) Shorter regimens improved treatment outcomes of multidrug‐resistant tuberculosis patients in Tanzania in 2018 cohort. Tropical Medicine & International Health 28:5, pages 357-366.
Crossref
Crossref
Jiamin He, Zheng Zhu, Meiyan Sun, Xiaoning Liu, Junwen Yu, Lin Zhang & Hongzhou Lu. (2023) Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review. Frontiers in Pharmacology 14.
Crossref
Crossref
Juliet Addo, Dave Pearce, Marilyn Metcalf, Courtney Lundquist, Gillian Thomas, David Barros-Aguirre, Gavin C. K. W. Koh & Mike Strange. (2022) Living with tuberculosis: a qualitative study of patients’ experiences with disease and treatment. BMC Public Health 22:1.
Crossref
Crossref
Alexandra Rodrigues dos Santos Silva, Paula Hino, Maria Rita Bertolozzi, Julia Couto de Oliveira, Marcos Vinícius de Freitas Carvalho, Hugo Fernandes & Sumire Sakabe. (2022) Percepções de pessoas com tuberculose/HIV em relação à adesão ao tratamento. Acta Paulista de Enfermagem 35.
Crossref
Crossref
Hellen Musana, Jude Thaddeus Ssensamba, Mary Nakafeero, Henry Mugerwa, Flavia Matovu Kiweewa, David Serwadda & Francis Ssali. (2021) Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda. AIDS Research and Therapy 18:1.
Crossref
Crossref
Jennifer R Zelnick, Amrita Daftary, Christina Hwang, Amy S Labar, Resha Boodhram, Bhavna Maharaj, Allison K Wolf, Shinjini Mondal, K Rivet Amico, Catherine Orrell, Boitumelo Seepamore, Gerald Friedland, Nesri Padayatchi & Max R O’Donnell. (2021) Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus. Clinical Infectious Diseases 73:7, pages e1901-e1910.
Crossref
Crossref
Amrita Daftary, Shinjini Mondal, Jennifer Zelnick, Gerald Friedland, Boitumelo Seepamore, Resha Boodhram, K Rivet Amico, Nesri Padayatchi & Max R O'Donnell. (2021) Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study. The Lancet Global Health 9:4, pages e479-e488.
Crossref
Crossref
Philipp du Cros, Atadjan Khamraev, Zinaida Tigay, Tleubergen Abdrasuliev, Jane Greig, Graham Cooke, Krzysztof Herboczek, Tanya Pylypenko, Catherine Berry, Amrita Ronnachit, David Lister, Sebastian Dietrich, Cono Ariti, Khasan Safaev, Bern-Thomas Nyang'wa, Nargiza Parpieva, Mirzagalib Tillashaikhov & Jay Achar. (2021) Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan. ERJ Open Research 7:1, pages 00537-2020.
Crossref
Crossref
Jennifer Furin, Marian Loveday, Sindisiwe Hlangu, Lindy Dickson-Hall, Sacha le Roux, Mark Nicol & Helen Cox. (2020) “A very humiliating illness”: a qualitative study of patient-centered Care for Rifampicin-Resistant Tuberculosis in South Africa. BMC Public Health 20:1.
Crossref
Crossref
Kevin Wong, James Nguyen, Lillie Blair, Marina Banjanin, Bunraj Grewal, Shane Bowman, Hailey Boyd, Grant Gerstner, Hyun Jun Cho, David Panfilov, Cho Ki Tam, Delaney Aguilar & Vishwanath Venketaraman. (2020) Pathogenesis of Human Immunodeficiency Virus-Mycobacterium tuberculosis Co-Infection. Journal of Clinical Medicine 9:11, pages 3575.
Crossref
Crossref
Jeremy C. Kane, Melissa A. Elafros, Sarah M. Murray, Ellen M. H. Mitchell, Jura L. Augustinavicius, Sara Causevic & Stefan D. Baral. (2019) A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries. BMC Medicine 17:1.
Crossref
Crossref
Thomas W. McNally, Gilles de Wildt, Graciela Meza & Connie M. D. Wiskin. (2019) Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon – a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. BMC Health Services Research 19:1.
Crossref
Crossref
Atika Moosa, Tanuja N. Gengiah, Lara Lewis & Kogieleum Naidoo. (2019) Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study. BMC Infectious Diseases 19:1.
Crossref
Crossref
Fay Stephens, Neel R. Gandhi, James C.M. Brust, Koleka Mlisana, Pravi Moodley, Salim Allana, Angie Campbell & Sarita Shah. (2019) Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes 82:2, pages 124-130.
Crossref
Crossref
Collins Timire, John Z. Metcalfe, Joconiah Chirenda, Jerod N. Scholten, Barbara Manyame-Murwira, Mkhokheli Ngwenya, Ronnie Matambo, Kelvin Charambira, Herbert Mutunzi, Nico Kalisvaart & Charles Sandy. (2019) Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey. International Journal of Infectious Diseases 87, pages 119-125.
Crossref
Crossref
Zarir Udwadia & Jennifer Furin. (2019) Quality of drug-resistant tuberculosis care: Gaps and solutions. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 16, pages 100101.
Crossref
Crossref
Ian F. Walker, Oumin Shi, Joseph P. Hicks, Helen Elsey, Xiaolin Wei, Dick Menzies, Zhiyi Lan, Dennis Falzon, Giovanni Battista Migliori, Carlos Pérez-Guzmán, Mario H. Vargas, Lourdes García-García, José Sifuentes Osornio, Alfredo Ponce-De-León, Martie van der Walt & James N. Newell. (2019) Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients. European Respiratory Journal 54:1, pages 1800353.
Crossref
Crossref
John Metcalfe, Peter Bacchetti, Roy Gerona, Ali Esmail, Keertan Dheda & Monica Gandhi. (2019) Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB. ERJ Open Research 5:2, pages 00046-2019.
Crossref
Crossref
Jennifer Furin, Helen Cox & Madhukar Pai. (2019) Tuberculosis. The Lancet 393:10181, pages 1642-1656.
Crossref
Crossref
Kogieleum Naidoo & Nikita Naicker. 2019. HIV and Tuberculosis. HIV and Tuberculosis
9
23
.
Amrita DaftaryEllen M. H. MitchellMichael J. A. ReidEndalkachew FekaduEric Goosby. (2018) To End TB, First-Ever High-Level Meeting on Tuberculosis Must Address Stigma. The American Journal of Tropical Medicine and Hygiene 99:5, pages 1114-1116.
Crossref
Crossref
Neel R. Gandhi, James C.M. Brust & N. Sarita Shah. (2018) A new era for treatment of drug-resistant tuberculosis. European Respiratory Journal 52:4, pages 1801350.
Crossref
Crossref
Anja Reuter & Jennifer Furin. (2018) Optimal Management of Drug-Resistant Tuberculosis and Human Immunodeficiency Virus: an Update. Current Treatment Options in Infectious Diseases 10:1, pages 90-106.
Crossref
Crossref
Claire Penn & Jennifer WatermeyerClaire Penn & Jennifer Watermeyer. 2018. Communicating Across Cultures and Languages in the Health Care Setting. Communicating Across Cultures and Languages in the Health Care Setting
25
57
.
N. Gladys Kigozi, J. Christo Heunis, Michelle C. Engelbrecht, André P. Janse van Rensburg & H. C. J. Dingie van Rensburg. (2017) Tuberculosis knowledge, attitudes and practices of patients at primary health care facilities in a South African metropolitan: research towards improved health education. BMC Public Health 17:1.
Crossref
Crossref
Amrita Daftary, Mike Frick, Nandita Venkatesan & Madhukar Pai. (2017) Fighting TB stigma: we need to apply lessons learnt from HIV activism. BMJ Global Health 2:4, pages e000515.
Crossref
Crossref
Erika Mohr, Johnny Daniels, Busisiwe Beko, Petros Isaakidis, Vivian Cox, Sarah Jane Steele, Odelia Muller, Leigh Snyman, Virginia De Azevedo, Amir Shroufi, Laura Trivino Duran & Jennifer Hughes. (2017) DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting. PLOS ONE 12:5, pages e0178054.
Crossref
Crossref
Keertan Dheda, Tawanda Gumbo, Gary Maartens, Kelly E Dooley, Ruth McNerney, Megan Murray, Jennifer Furin, Edward A Nardell, Leslie London, Erica Lessem, Grant Theron, Paul van Helden, Stefan Niemann, Matthias Merker, David Dowdy, Annelies Van Rie, Gilman K H Siu, Jotam G Pasipanodya, Camilla Rodrigues, Taane G Clark, Frik A Sirgel, Aliasgar Esmail, Hsien-Ho Lin, Sachin R Atre, H Simon Schaaf, Kwok Chiu Chang, Christoph Lange, Payam Nahid, Zarir F Udwadia, C Robert HorsburghJrJr, Gavin J Churchyard, Dick Menzies, Anneke C Hesseling, Eric Nuermberger, Helen McIlleron, Kevin P Fennelly, Eric Goemaere, Ernesto Jaramillo, Marcus Low, Carolina Morán Jara, Nesri Padayatchi & Robin M Warren. (2017) The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The Lancet Respiratory Medicine 5:4, pages 291-360.
Crossref
Crossref
Nesri Padayatchi, Naressa Naidu, Gerald Friedland, Kasavan Naidoo, Francesca Conradie, Kogieleum Naidoo & Max Roe O’Donnell. (2017) Turning the tide against tuberculosis. International Journal of Infectious Diseases 56, pages 6-9.
Crossref
Crossref
Shona Horter, Beverley Stringer, Jane Greig, Akhmet Amangeldiev, Mirzagaleb N. Tillashaikhov, Nargiza Parpieva, Zinaida Tigay & Philipp du Cros. (2016) Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan. BMC Infectious Diseases 16:1.
Crossref
Crossref
Elisa Lopez-Varela, Victor Guillermo Sequera, Alberto L. García-Basteiro, Orvalho Joaquim Augusto, Khatia Munguambe, Jahit Sacarlal & Pedro L. Alonso. (2016) Adherence to Childhood Tuberculosis Treatment in Mozambique. Journal of Tropical Pediatrics, pages fmw048.
Crossref
Crossref
Ernesha Webb Mazinyo, Lindsay Kim, Sikhethiwe Masuku, Joey L. Lancaster, Ronel Odendaal, Margot Uys, Laura Jean Podewils & Martie L. Van der Walt. (2016) Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008–2010. PLOS ONE 11:7, pages e0159317.
Crossref
Crossref
Jennifer Furin & Petros Isaakidis. (2016) The tuberculosis emergency in eastern Europe. The Lancet HIV 3:3, pages e107-e108.
Crossref
Crossref
Beena Elizabeth Thomas, Poonguzhali Shanmugam, Muniyandi Malaisamy, Senthanro Ovung, Chandra Suresh, Ramnath Subbaraman, Srividya Adinarayanan & Karikalan Nagarajan. (2016) Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review. PLOS ONE 11:1, pages e0147397.
Crossref
Crossref
Chandy Sara, Heylen Elsa, Mishra Baijayanti & Ekstrand Maria Lennartsdotter. (2016) Clinical Correlates and Drug Resistance in HIV-Infected and -Uninfected Pulmonary Tuberculosis Patients in South India. World Journal of AIDS 06:03, pages 87-100.
Crossref
Crossref
Stella Benbaba, Petros Isaakidis, Mrinalini Das, Sonakshi Jadhav, Tony Reid & Jennifer Furin. (2015) Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?. PLOS ONE 10:12, pages e0144936.
Crossref
Crossref
John Z. Metcalfe, Max R. O’Donnell & David R. Bangsberg. (2015) Moving Beyond Directly Observed Therapy for Tuberculosis. PLOS Medicine 12:9, pages e1001877.
Crossref
Crossref
Karen Blake Jacobson, Matthew Tate, Francois Eksteen, Anthony Moll, Nesri Padayatchi, Gerald Friedland & Sheela Shenoi. (2015) Care of the patient with XDR-TB who has failed treatment. The Lancet Respiratory Medicine 3:4, pages 269-270.
Crossref
Crossref
Amrita Daftary, Liviana Calzavara & Nesri Padayatchi. (2015) The contrasting cultures of HIV and tuberculosis care. AIDS 29:1, pages 1-4.
Crossref
Crossref